Metropolis Healthcare Limited has completed the transfer of its External Quality Assessment Services Business Division (EQAS Division) to its subsidiary, Metropolis Quality Solutions Private Limited (MQSPL).
The transaction was executed as a slump sale of the entire business division as a going concern, effective August 27, 2026. The transfer was completed pursuant to a Business Transfer Agreement between the parties.
The consideration for the transaction amounted to INR 1.25 crore. This consideration was discharged through the issuance of equity shares of MQSPL to Metropolis Healthcare Limited, in accordance with the agreed terms under the Business Transfer Agreement.
With effect from August 27, 2026, all operations relating to the EQAS Division are being carried out by MQSPL. This disclosure is made in continuation of earlier intimations dated February 04, 2026 and August 04, 2026, and under Regulation 30 of the SEBI Listing Regulations.
The disclosure was signed by Kamlesh C Kulkarni, Head – Legal & Secretarial of Metropolis Healthcare Limited.